Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review
Markus S. Anker, Richard Holcomb, Maurizio Muscaritoli, et al.
Journal of Cachexia Sarcopenia and Muscle (2019) Vol. 10, Iss. 1, pp. 22-34
Open Access | Times Cited: 157

Showing 1-25 of 157 citing articles:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2021) Vol. 42, Iss. 36, pp. 3599-3726
Open Access | Times Cited: 8910
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 1, pp. 4-131
Open Access | Times Cited: 1537
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2019
Stephan von Haehling, John E. Morley, Andrew J.S. Coats, et al.
Journal of Cachexia Sarcopenia and Muscle (2019) Vol. 10, Iss. 5, pp. 1143-1145
Open Access | Times Cited: 389
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021
Stephan von Haehling, Andrew J.S. Coats, Stefan D. Anker
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 6, pp. 2259-2261
Open Access | Times Cited: 362
The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review
Paolo Bossi, Paolo Delrio, Annalisa Mascheroni, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1980-1980
Open Access | Times Cited: 275
Inflammation and Skeletal Muscle Wasting During Cachexia
Justine Webster, Laura JAP Kempen, Rowan Hardy, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 243
<p>Cancer Cachexia: Definition, Staging, and Emerging Treatments</p>
Jun Ni, Li Zhang
Cancer Management and Research (2020) Vol. Volume 12, pp. 5597-5605
Open Access | Times Cited: 182
Understanding cachexia in the context of metastatic progression
Anup Biswas, Swarnali Acharyya
Nature reviews. Cancer (2020) Vol. 20, Iss. 5, pp. 274-284
Closed Access | Times Cited: 160
The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia
Aldona Kasprzak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1565-1565
Open Access | Times Cited: 118
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 6, pp. 523.e1-523.e114
Closed Access | Times Cited: 90
Mitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies
Gökhan Burçin Kubat, Esmaa Bouhamida, Öner Ülger, et al.
Mitochondrion (2023) Vol. 72, pp. 33-58
Closed Access | Times Cited: 50
Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studies
Agnès Martin, Yann S. Gallot, Damien Freyssenet
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 3, pp. 1150-1167
Open Access | Times Cited: 48
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia
Hidenori Arai, Keisuke Maeda, Hidetaka Wakabayashi, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 5, pp. 1949-1958
Open Access | Times Cited: 47
Weight Gain Among Cancer Patients Receiving Chemotherapy—Facts and Numbers
Muhammad Shahzeb Khan, Javed Butler, Markus S. Anker
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Rudolf A. de Boer, Jean‐Sébastien Hulot, Carlo G. Tocchetti, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 12, pp. 2272-2289
Open Access | Times Cited: 138
Weight loss, malnutrition, and cachexia in COVID‐19: facts and numbers
Markus S. Anker, Ulf Landmesser, Stephan von Haehling, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 12, Iss. 1, pp. 9-13
Open Access | Times Cited: 127
Cancer Cachexia and Related Metabolic Dysfunction
Guilherme Wesley Peixoto da Fonseca, Jerneja Farkaš, Eva Dora, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2321-2321
Open Access | Times Cited: 88
Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options
Gioacchino P. Marceca, Priya Londhe, Federica Calore
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 77
Mitochondrial Dysfunction Is a Common Denominator Linking Skeletal Muscle Wasting Due to Disease, Aging, and Prolonged Inactivity
Hayden W. Hyatt, Scott K. Powers
Antioxidants (2021) Vol. 10, Iss. 4, pp. 588-588
Open Access | Times Cited: 68
Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies
Agnès Martin, Damien Freyssenet
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 2, pp. 252-273
Open Access | Times Cited: 65
The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy
José Antônio Fagundes Assumpção, Gabriel Pasquarelli-do-Nascimento, Mariana Saldanha Viegas Duarte, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 52
HPLC, FTIR and GC-MS Analyses of Thymus vulgaris Phytochemicals Executing In Vitro and In Vivo Biological Activities and Effects on COX-1, COX-2 and Gastric Cancer Genes Computationally
Ayesha Saleem, Muhammad Afzal, Muhammad Naveed, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8512-8512
Open Access | Times Cited: 47
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: Update 2023
Stephan von Haehling, Andrew J.S. Coats, Stefan D. Anker
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 6, pp. 2981-2983
Open Access | Times Cited: 23
AMPK as a mediator of tissue preservation: time for a shift in dogma?
Henning T. Langer, Maria Rohm, Marcus D. Goncalves, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 9, pp. 526-540
Closed Access | Times Cited: 12
Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC‐1 study design
John D. Groarke, Jeffrey Crawford, Susie M. Collins, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 3, pp. 1054-1061
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top